Across TCGA pan-cancer cohorts, SNHG32 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SNHG32 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SNHG32 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SNHG32 expression acts as an unfavorable survival marker.

LUAD and DLBC are the cancer types where SNHG32 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.223	0.812	<.001	27	view →
DLBC	DFS	Median	II,III,IV	0.065	0.829	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: SNHG32 tumor-vs-normal RNA expression · all SNHG32 data types